Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Study locations have been updated, with new sites added across the United States and other countries and some existing sites removed. This changes the geographic availability of enrollment for the PICCOLO trial.
    Difference
    0.3%
    Check dated 2025-11-03T01:19:26.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    - Added a government operating status notice and updated operating details. - Updated version from v3.1.0 to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:34:27.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    - Added a new version tag (v3.1.0). - Removed a specific resource (ovarian cancer) from the Genetic and Rare Diseases Information Center resources and removed the older version tag (v3.0.2).
    Difference
    0.3%
    Check dated 2025-09-28T03:24:07.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:43:51.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T15:29:13.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional drug information for mirvetuximab soravtansine and relevant publications. Some previously listed locations and related topics have been removed.
    Difference
    6%
    Check dated 2025-08-30T12:13:55.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.